HRTX FY 2012 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HRTXHeron Therapeutics, Inc.

$152M

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$646,000+0.0% YoY

Gross Profit

-$14M-2178.8% margin

Operating Income

-$24M-3689.0% margin

Net Income

-$23M-3614.2% margin

EPS (Diluted)

$-1.91

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$18M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$56M

Total Liabilities

$4M

Stockholders' Equity

$52M

Cash & Equivalents

$54M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$646,000	$646,000	+0.0%
Gross Profit	-$14M	$467,000	-3113.9%
Operating Income	-$24M	-$11M	-115.4%
Net Income	-$23M	-$12M	-97.6%